Package 51655-315-26

{"route": ["ORAL"], "spl_id": "48eaf857-c4e5-3f5e-e063-6294a90ac0de", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897666"], "spl_set_id": ["f2f059a1-0cf9-a5d6-e053-2a95a90a3dab"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (51655-315-26)", "package_ndc": "51655-315-26", "marketing_start_date": "20230203"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (51655-315-52)", "package_ndc": "51655-315-52", "marketing_start_date": "20221123"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "51655-315_48eaf857-c4e5-3f5e-e063-6294a90ac0de", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51655-315", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA071881", "marketing_category": "ANDA", "marketing_start_date": "20221123", "listing_expiration_date": "20271231"}